Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06371157
What this trial is testing

AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Akeso 469
Not applicableStudy completedNCT02692365
What this trial is testing

Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI

Who this might be right for
Primary or Metastatic Tumor in the Liver Parenchyma
Hospital Sirio-Libanes 20
Testing effectiveness (Phase 2)Looking for participantsNCT06978933
What this trial is testing

FGF19 Overexpression Combination Unified Study in HCC-19

Who this might be right for
HCC - Hepatocellular Carcinoma
RenJi Hospital 42
Testing effectiveness (Phase 2)Study completedNCT01967823
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

Who this might be right for
MelanomaMeningiomaBreast Cancer+2 more
National Cancer Institute (NCI) 11
Not applicableStudy completedNCT03741088
What this trial is testing

Study to Evaluate VORTX Rx (Theresa)

Who this might be right for
Carcinoma, HepatocellularLiver Metastases
HistoSonics, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00006010
What this trial is testing

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Alliance for Clinical Trials in Oncology 25
Testing effectiveness (Phase 2)UnknownNCT02184182
What this trial is testing

Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)

Who this might be right for
Liver Tumors
Azienda Ospedaliera di Padova 10
Not applicableWithdrawnNCT05240040
What this trial is testing

Treat Primary and Metastatic Liver Tumors

Who this might be right for
Intrahepatic CholangiocarcinomaLiver TumorMetastatic Cancer+1 more
Methodist Health System
Not applicableStudy completedNCT03176485
What this trial is testing

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Who this might be right for
Metastatic CancerMelanomaColon Cancer+6 more
University of Arizona 45
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune, Inc. 50
Not applicableStudy completedNCT00728650
What this trial is testing

A Retrospective Review of Malignant Liver Tumors

Who this might be right for
Liver Cancer
University of Oklahoma 228
Not applicableActive Not RecruitingNCT02119065
What this trial is testing

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Who this might be right for
Advanced Adult Primary Liver CancerLiver MetastasesLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Cincinnati 6
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Ended earlyNCT00658593
What this trial is testing

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
NCIC Clinical Trials Group 19
Early research (Phase 1)Looking for participantsNCT06478693
What this trial is testing

MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC

Who this might be right for
Hepatocellular Carcinoma
Myeloid Therapeutics 70
Testing effectiveness (Phase 2)Looking for participantsNCT07227012
What this trial is testing

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Who this might be right for
Carcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more
Pfizer 138
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Not applicableUnknownNCT03416803
What this trial is testing

Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma

Who this might be right for
Lymph Node MetastasisHepatocellular CarcinomaRadiotherapy
Shanghai Zhongshan Hospital 150
Next Page